Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
Clinical trial NCT01205334 · TERMINATED
Trial details
- NCT number
- NCT01205334
- Sponsor
- Baylor College of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2012-01-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.